Fas-mediated pathway and apoptosis in normal cervix, cervical intraepithelial neoplasia and cervical squamous cancer
- PMID: 16820908
Fas-mediated pathway and apoptosis in normal cervix, cervical intraepithelial neoplasia and cervical squamous cancer
Abstract
The aim of this study was to examine the expression patterns of apoptosis-related antigens, such as Fas, FasL, and cFLIP, in cervical squamous cells, and investigate the role of Fas-mediated apoptosis in the pathogenesis of cervical neoplasia. Using specific antibodies for Fas, FasL, and cFLIP, we examined protein expression in 19 specimens of normal cervix, 15 mild dysplasia (CIN I), 22 moderate dysplasia (CIN II), 23 severe dysplasia (CIN III), and 34 invasive squamous cell carcinoma (SCC) by immunohistochemistry. We detected the apoptotic indices by TUNEL in the same specimens. Fas expression levels were quite similar in CIN I, CIN II and the normal cervix. Though Fas expression tended to increase in grade 2 cancer compared to grade 1 cancer and CIN III, and a slight decline was present in grade 3 compared with grade 2 cancer, these differences did not reach statistical significance. Almost all CINs did not express FasL, while FasL expression increased with the grade of the tumor. Statistically significant differences could be observed between grade 1 and grade 2 (p<0.01) and between grade 2 plus grade 3 and grade 1 (p<0.001). All cases of normal cervix and CIN, except two cases of CIN III, did not express cFLIP. cFLIP expression tended to increase with the grade of the tumor. Apoptosis was determined in all samples by TUNEL. There was a decreasing tendency of apoptotic cells from normal cervix to cancers. A negative correlation between cFLIP and apoptosis (r=-0.499 and p=0.000) was observed. Deregulated Fas/FasL system and constitutive expression of cFLIP in SCC may be an important mechanism by which SCCs escape apoptosis during the malignant transformation and progression of these tumors.
Similar articles
-
Death receptors and ligands in cervical carcinogenesis: an immunohistochemical study.Gynecol Oncol. 2005 Mar;96(3):705-13. doi: 10.1016/j.ygyno.2004.10.046. Gynecol Oncol. 2005. PMID: 15721415
-
Altered expression of cellular membrane molecules of HLA-DR, HLA-G and CD99 in cervical intraepithelial neoplasias and invasive squamous cell carcinoma.Life Sci. 2006 Apr 25;78(22):2643-9. doi: 10.1016/j.lfs.2005.10.039. Epub 2006 Jan 24. Life Sci. 2006. PMID: 16434060
-
Expressions of IGFBP-5, cFLIP in cervical intraepithelial neoplasia, cervical carcinoma and their clinical significances: a molecular pathology.J Exp Clin Cancer Res. 2009 May 28;28(1):70. doi: 10.1186/1756-9966-28-70. J Exp Clin Cancer Res. 2009. PMID: 19476635 Free PMC article.
-
Coordinate expression of cytokeratin 8 and cytokeratin 17 immunohistochemical staining in cervical intraepithelial neoplasia and cervical squamous cell carcinoma: an immunohistochemical analysis and review of the literature.Gynecol Oncol. 2008 Mar;108(3):598-602. doi: 10.1016/j.ygyno.2007.11.042. Epub 2008 Jan 14. Gynecol Oncol. 2008. PMID: 18191996 Review.
-
Octamer binding transcription factor-4 expression is associated with cervical cancer malignancy and histological differentiation: a systematic review and meta-analysis.Biosci Rep. 2019 May 10;39(5):BSR20182328. doi: 10.1042/BSR20182328. Print 2019 May 31. Biosci Rep. 2019. PMID: 30979828 Free PMC article.
Cited by
-
Corticotropin-releasing hormone (CRH) is expressed in the human cervical carcinoma cells (HeLa) and upregulates the expression of Fas ligand.Tumour Biol. 2013 Feb;34(1):125-30. doi: 10.1007/s13277-012-0519-8. Epub 2012 Oct 18. Tumour Biol. 2013. PMID: 23076876
-
Immunosuppressive tumor microenvironment in cervical cancer patients.Cancer Microenviron. 2011 Dec;4(3):361-75. doi: 10.1007/s12307-011-0066-7. Epub 2011 May 31. Cancer Microenviron. 2011. PMID: 21626415 Free PMC article.
-
Fas and Fas ligand are highly expressed in lymphocytes from cervical intraepithelial neoplasia and cervical cancer patients: A possible role for immune escaping.Iran J Basic Med Sci. 2022 Mar;25(3):383-389. doi: 10.22038/IJBMS.2022.61808.13678. Iran J Basic Med Sci. 2022. PMID: 35656191 Free PMC article.
-
Promoter polymorphism of FASL confers protection against female-specific cancers and those of FAS impact the cancers divergently.Tumour Biol. 2015 Apr;36(4):2709-24. doi: 10.1007/s13277-014-2896-7. Epub 2014 Dec 4. Tumour Biol. 2015. PMID: 25472583
-
The immune microenvironment of cancer of the uterine cervix.Histol Histopathol. 2024 Oct;39(10):1245-1271. doi: 10.14670/HH-18-727. Epub 2024 Mar 1. Histol Histopathol. 2024. PMID: 38483012 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous